Overall Survival Benefits of First-Line Treatments for Asian Patients with Advanced Epidermal Growth Factor Receptor-Mutated NSCLC Harboring Exon 19 Deletion: A Systematic Review and Network Meta-Analysis

SIMPLE SUMMARY: Survival benefits and clinical responsiveness have been exhibited by various generations of EGFR-tyrosine kinase inhibitors (TKIs) in numerous randomized-controlled trials for EGFR-mutated advanced non-small-cell lung cancer (NSCLC) over the past two decades. However, the efficacy, e...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Sik-Kwan, Choi, Horace Cheuk-Wai, Lee, Victor Ho-Fun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316403/
https://www.ncbi.nlm.nih.gov/pubmed/35884423
http://dx.doi.org/10.3390/cancers14143362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316403/
https://www.ncbi.nlm.nih.gov/pubmed/35884423
http://dx.doi.org/10.3390/cancers14143362

Ejemplares similares